Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Travel grant 2025 Switzerland, SWISS NORDIC BIO, March 12-13
| Reference number | 2025-00027 |
| Coordinator | Dicot Pharma AB |
| Funding from Vinnova | SEK 0 |
| Project duration | March 2025 - March 2025 |
| Status | Completed |
| Venture | Global cooperation 2025 |
The target was met, valuable contacts were established.
Established contacts with international investors.
Participation in Swiss Nordic Bio 2025 including side events.
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
Last updated 28 March 2025
Reference number 2025-00027
